Empower Clinics weltweit erste Cannabis Klinik - Älteste Beiträge zuerst (Seite 46)
eröffnet am 02.04.19 14:56:27 von
neuester Beitrag 28.03.24 09:05:02 von
neuester Beitrag 28.03.24 09:05:02 von
Beiträge: 6.034
ID: 1.301.202
ID: 1.301.202
Aufrufe heute: 0
Gesamt: 517.919
Gesamt: 517.919
Aktive User: 0
ISIN: CA29246V1040 · WKN: A2JKED · Symbol: EPW
0,0100
CAD
0,00 %
0,0000 CAD
Letzter Kurs 20.06.23 CSE
Neuigkeiten
19.08.23 · Accesswire  |
15.08.23 · Accesswire |
09.08.23 · Accesswire |
01.08.23 · Accesswire |
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,8300 | +161,43 | |
| 9,2900 | +20,96 | |
| 111,75 | +18,87 | |
| 0,6400 | +18,52 | |
| 1,0900 | +14,74 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,5058 | -12,79 | |
| 9,7200 | -19,60 | |
| 14,510 | -32,32 | |
| 8,0000 | -36,76 | |
| 1.160,00 | -42,00 |
Feedback
2019-11-07 09:07 ET - News Release
Mr. Steven McAuley reports
EMPOWER CLINICS ANNOUNCES RECORD PRELIMINARY UNAUDITED Q3 2019 REVENUE WITH 138% YEAR OVER YEAR INCREASE AND DETAILS FOR RELEASE OF FINANCIAL STATEMENTS
Empower Clinics Inc. had preliminary unaudited year-over-year revenue growth of 138 per cent for the three months ended Sept. 30, 2019. The company also decreased total direct clinic expenses by approximately 40%, while adding six new clinics as a result of the Sun Valley clinics acquisition.
The Company also has patient visits in corporate clinics increase by triple digits, with October 2019 patients seen increasing by 336% to 1,847 versus October 2018 with 550 patients seen.
"The Company is starting to feel the positive impact that the Sun Valley clinics acquisition has provided with their strong operational performance in Arizona, in conjunction with continued cost cutting measures with operations in Oregon and Washington State," said Steven McAuley, CEO of Empower. "We have also been able to integrate key back office, admin, payroll & human resource functions from the Pacific Northwest into the operational controls of Sun Valley, bringing improved productivity to the organization."
As part of the Company's continued expansion of our health & wellness clinic model, we have already set up retail CBD product sales in-clinic, and now we have launched expanded physician based services starting with key Arizona clinics.
New Modalities and Services:
Physician's CBD Enhanced Massage, Acupuncture, or Cupping Sessions
CBD-Cannabis-Supplement Consumption & Coaching Consultation
Introduction to Alternative Health and Cannabinoid Therapies by a Physician
Comprehensive Naturopathic Patient Analysis & Consultation
Dietary Antigen Testing, Physician Consultation/Action Plan, & Concierge Blood Draw
Neurotransmitter (urine) Profile & Physician Consultation/Action Plan
Spectracell Micronutrient Test & Physician Consultation/Action Plan
Empower plans to release its third quarter results ending September 30 th, 2019 on November 14, 2019 at 9:00AM Eastern time.
Financial Measures
This news release makes reference to certain non-IFRS measures, including certain industry metrics. These metrics and measures are not recognized measures under IFRS do not have meanings prescribed under IFRS and are as a result unlikely to be comparable to similar measures presented by other companies. These measures are provided as information complimentary to those IFRS measures by providing a further understanding of our operating results from the perspective of management. As such, these measures should not be considered in isolation or in lieu of review of our financial information reported under IFRS. These non-IFRS measures, including the industry measures, are used to provide investors with supplementary measures of our operating performance that may not otherwise be apparent when relying solely on IFRS metrics.
ABOUT EMPOWER
Empower is a vertically-integrated health & wellness brand with it's first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.
Mr. Steven McAuley reports
EMPOWER CLINICS ANNOUNCES RECORD PRELIMINARY UNAUDITED Q3 2019 REVENUE WITH 138% YEAR OVER YEAR INCREASE AND DETAILS FOR RELEASE OF FINANCIAL STATEMENTS
Empower Clinics Inc. had preliminary unaudited year-over-year revenue growth of 138 per cent for the three months ended Sept. 30, 2019. The company also decreased total direct clinic expenses by approximately 40%, while adding six new clinics as a result of the Sun Valley clinics acquisition.
The Company also has patient visits in corporate clinics increase by triple digits, with October 2019 patients seen increasing by 336% to 1,847 versus October 2018 with 550 patients seen.
"The Company is starting to feel the positive impact that the Sun Valley clinics acquisition has provided with their strong operational performance in Arizona, in conjunction with continued cost cutting measures with operations in Oregon and Washington State," said Steven McAuley, CEO of Empower. "We have also been able to integrate key back office, admin, payroll & human resource functions from the Pacific Northwest into the operational controls of Sun Valley, bringing improved productivity to the organization."
As part of the Company's continued expansion of our health & wellness clinic model, we have already set up retail CBD product sales in-clinic, and now we have launched expanded physician based services starting with key Arizona clinics.
New Modalities and Services:
Physician's CBD Enhanced Massage, Acupuncture, or Cupping Sessions
CBD-Cannabis-Supplement Consumption & Coaching Consultation
Introduction to Alternative Health and Cannabinoid Therapies by a Physician
Comprehensive Naturopathic Patient Analysis & Consultation
Dietary Antigen Testing, Physician Consultation/Action Plan, & Concierge Blood Draw
Neurotransmitter (urine) Profile & Physician Consultation/Action Plan
Spectracell Micronutrient Test & Physician Consultation/Action Plan
Empower plans to release its third quarter results ending September 30 th, 2019 on November 14, 2019 at 9:00AM Eastern time.
Financial Measures
This news release makes reference to certain non-IFRS measures, including certain industry metrics. These metrics and measures are not recognized measures under IFRS do not have meanings prescribed under IFRS and are as a result unlikely to be comparable to similar measures presented by other companies. These measures are provided as information complimentary to those IFRS measures by providing a further understanding of our operating results from the perspective of management. As such, these measures should not be considered in isolation or in lieu of review of our financial information reported under IFRS. These non-IFRS measures, including the industry measures, are used to provide investors with supplementary measures of our operating performance that may not otherwise be apparent when relying solely on IFRS metrics.
ABOUT EMPOWER
Empower is a vertically-integrated health & wellness brand with it's first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.
https://thecse.com/en/listings/life-sciences/empower-clinics…
unfassbar selbst zudem niedrigen Kurs wird weiter verkauft 183.000 bei 0,045 CAD im ASK
unfassbar selbst zudem niedrigen Kurs wird weiter verkauft 183.000 bei 0,045 CAD im ASK
Es wird alles im Sektor verprügelt. Wahnsinn 😳
Trading Spotlight
Empower Clinics behebt den Rückgang von Cannabis mit 137% mehr Einnahmen und 211% mehr Patientenbesuchen
Quelle: https://agoracom.com/ir/EmpowerClinics/forums/discussion/top…
Quelle: https://agoracom.com/ir/EmpowerClinics/forums/discussion/top…
https://thecse.com/en/listings/life-sciences/empower-clinics…
immer noch ein sehr großes Position im Ask und so gut wie kein Bid mehr vorhanden.
immer noch ein sehr großes Position im Ask und so gut wie kein Bid mehr vorhanden.
Kaum Umsätze vorhanden...
Antwort auf Beitrag Nr.: 61.972.487 von BlackView am 20.11.19 15:33:2925 % Minus in Kanada. Wenn der mit seinen 207-000 Stücken die Nerven verliert sehen wir 0,005 CAD
Kann ich mir kaum vorstellen, da der potsector gerade grün ist... 💚✔️
DurchsuchenBeitrag zu dieser Diskussion schreiben
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| -0,21 | |
| -1,70 | |
| -3,62 | |
| +1,68 | |
| +8,61 | |
| -5,00 | |
| -9,44 | |
| 0,00 | |
| +1,57 | |
| -5,88 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 204 | ||
| 190 | ||
| 155 | ||
| 68 | ||
| 32 | ||
| 29 | ||
| 28 | ||
| 26 | ||
| 26 | ||
| 25 |
